tirzepatide for the treatment of obstructive sleep apnea Medscape | FDA approved Zepbound in December 2024 the moderate-to-severe in patients with obesity after FDA Approves First Sleep Apnea

The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutide

BBB profiles in both Lehi UT and Gilbert AZ show recurring complaints about delayed delivery, the 2-month minimum disclosure, and FSA cancellation friction

The average participant getting a 12-mg weekly injection lost 71 pounds in 68 weeks

Important note for people with type 2 diabetes: Some medicines used to treat type 2 diabetes, including SGLT2 inhibitors (such as dapagliflozin, empagliflozin, and canagliflozin), carry a risk of euglycaemic diabetic ketoacidosis (DKA) a serious condition in which ketone levels become dangerously high even when blood glucose appears normal

So ultra-processed food makes you fat, right